Setting new standards in information exchange for the pharmaceutical and biotech industry
Meet The PODD 2015 Keynotes
July 10, 2015
PODD: Partnership Opportunities in Drug Delivery 2015 is delighted to announce the keynote speakers. The annual keynote address with Dr Robert Langer, David H. Koch Institute Professor, MIT is scheduled to open the program on October 5th and the focus will be on nanotechnology.
Following Dr Langer for the first time at PODD, we are pleased to welcome Dr Bahija Jallal, EVP, AstraZeneca, Head of MedImmune address a number of challenging centered around culture, innovation and change. She will be joined by PODD veteran and colleague Dr Anand Subramony, VP, Drug Delivery & Device Development, MedImmune.
Lastly and also new to the program, Stéphane Bancel, CEO, Moderna Therapeutics is scheduled to keynote on October 6th. His company was recently names #1 Disruptor on the third-annual CNBC Disruptor 50 list. For the second year in a row, CNBC recognized Moderna as one of the country’s most ambitious and innovative companies changing the economy and overall business landscape.
PODD is a strategic level conference for professionals in the pharma, biotech, drug delivery and investor space looking for a thorough overview of the latest drug delivery technologies along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug. The conference includes and facilitates ample networking time and services for one-on-one meetings. PODD is chaired by Dr Barbara Lueckel, Head of Research & Technologies Partnering at Roche.
For more about the PODD Conference visit: http://theconferenceforum.org/conferences/partners-in-drug-delivery/overview/